Generated positive cash flow of $0.4 million, a substantial improvement compared to $10.0 million cash used in the third quarter of 2023, reflecting continued operational discipline and significant ...
Welcome to Elanco Animal Health third-quarter 2024 earnings conference call. [Operator instructions] I would now like to hand the call over to Katy Grissom, head of investor relations. You may begin ...
Ayvakit has been recommended by NICE for ASM – an umbrella term that covers aggressive systemic mastocytosis, systemic mastocytosis with an associated haematological neoplasm (SM-AHN), and mast cell ...